April 7, 2017 · STOCK Act disclosure
Representative Michael T. McCaul (Republican-TX) bought Regeneron Pharmaceuticals, Inc., a stock transaction, valued at $1,001 - $15,000. The trade took place on April 7, 2017 and was disclosed on May 26, 2017 (owner: DC). Members of Congress must report such transactions within 45 days under the STOCK Act.